BrosMed Establishes Europe Subsidiary in the Netherlands
Release time:
2014-09-02
September 2, 2014, BrosMed Medical has announced the establishment of a subsidiary company in the Netherlands, BrosMed Medical B.V.
September 2, 2014, BrosMed Medical has announced the establishment of a subsidiary company in the Netherlands, BrosMed Medical B.V.
The new company will assume direct responsibility for the sales and marketing of BrosMed Medical’s products for the Europe, Latin American, Middle East, Asia Pacific and Ocean Pacific territories.
Mr. Jos A.W.J de Korte is appointed as general manager of BrosMed B.V. which is approved by the board of BrosMed Medical. He brings over 15 years leadership experience of sales and marketing in medical device industry to the position having served as VP Sales and Business Development Cappella Ltd Ireland, Executive Vice President Sales and Marketing MicroPort Scientific China, Executive VP sales and Marketing Blue Medical BV, The Netherlands and VP Sales and Business Development Biocompatibles Ltd. UK.
“The BrosMed B.V. establishment is a key milestone of BrosMed Medical to its goals of global medical device company. Mr. Jos A.W.J de Korte comes at an important time in the growth of BrosMed Medical,” said by Benny Lee, chairman of the company. “We are confident that BrosMed B.V. will enhance sales & marketing and customer services to the next level under the leadership of Mr. Jos A.W.J de Korte”.
For more information about BrosMed B.V., please contact cs@brosmed.com
About BrosMed Medical
BrosMed Medical is more than just a company; we are leading the medical device design and manufacturing revolution.
BrosMed Medical develops, manufactures and markets medical devices primarily used by interventional cardiologists, radiologists and vascular surgeons in angioplasty procedures and other minimal invasive devices.
We provide solutions to our customers through innovative design, effective supply chain management, world-class manufacturing, and flexible channels of distribution and through the development or acquisition of innovative technologies.
Join with Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announced CE MDR Approval of New Generation Conger™ Plus Hydrophilic Guidewires
Designed for superior crossability and maneuverability in peripheral interventions, Conger Plus now offers 116 models with expanded sizes (OD 0.018'' to 0.038'') and lengths (up to 300cm).
2025-04-25
Meet BrosMed at ESC Congress 2024
BrosMed Medical is delighted to participate in the ESC Congress 2024 from August 30th to September 2nd in London, UK.
2024-08-15
BrosMed Medical Announces Scott J. Addonizio as Chief Operating Officer
2024 August 1st – BrosMed Medical is pleased to announce the appointment of Scott J. Addonizio as its Chief Operating Officer (COO), effective immediately. Mr. Scott J. Addonizio brings a wealth of experience and expertise to BrosMed, with a distinguished career spanning almost 30 years in the medical device industry. Prior to joining BrosMed, Mr. Addonizio served as SVP at Cordis and COO at MedAlliance Swiss Medical Technology.
2024-08-01
CTO&CHIP PCI – Insights from the clinical practice (Ⅱ)
July 30, 2024 @16:00-17:30 (Beijing Time) Join BrosMed Medical on Tuesday, July 30 for an enlightening discussion that unites cardiologists from Malaysia, China, India, Tunisia and Portugal, where clinical expertise harmoniously fuses with CTO&CHIP innovation. At this exclusive webinar, we’re orchestrating a confluence of valuable insights, drawing from the collective wisdom of seasoned interventional cardiologists.
2024-07-26
BrosMed Announced CE MDR Approval of New Generation PTA SC Balloon Dilatation Catheters
May 27, 2024- BrosMed announced that it receives European Medical Device Regulation (MDR) certification for the New Generation PTA SC Balloon Dilatation Catheters (Brand Name: Polux™ Pro 014, Minerva™ Pro 018 and Atropos™ Pro 035).
2024-05-27